Genetics of essential hypertension: From families to genes

Journal of the American Society of Nephrology

Volumn 13, Issue SUPPL. 3, 2002, Pages

  Barlassina, Cristina ^a   Lanzani, Chiara ^a   Manunta, Paolo ^a   Bianchi, Giuseppe ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADDUCIN; ALDOSTERONE SYNTHASE; DIPEPTIDYL CARBOXYPEPTIDASE;

AGE; BIOMETRY; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; EVALUATION; FAMILIAL DISEASE; FEEDBACK SYSTEM; FOLLOW UP; GENE FREQUENCY; GENE SEGREGATION; GENETIC ANALYSIS; GENETIC EPISTASIS; GENETIC VARIABILITY; HUMAN; INCIDENCE; MOLECULAR GENETICS; MONOGENIC DISORDER; MULTIFACTORIAL INHERITANCE; OBSERVATION; PHENOMENOLOGY; POPULATION RISK; PRIORITY JOURNAL; VALIDATION PROCESS;

EID: 0036839782     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (99)

1. Ward R: Familial aggregation and genetic epidemiology of blood pressure. In: Hypertension: Pathophysiology, Diagnosis and Management, Vol.1, edited by Laragh JH, Brenner BM, New York, Raven Press, 1990, pp 81-100
2. Biron P, Mongeau JG: Familial aggregation of blood pressure and its components. Pediat Clin 25: 29-33, 1978
3. Biron P, Mongeau JG, Bertrand D: Familial aggregation of blood pressure in 588 adopted children. Can Med Assoc J 115: 773-774, 1976
4. Mongeau JG, Biron P, Sing CF: The influence of genetics and household environment upon the variability of normal blood pressure: The Montreal adoption survey. Clin Exper Hypertens A8: 653-666, 1986
5. Miall WE, Henage P, Khosal T, Lovell HG, Moore P: Factors influencing the degree of resemblance in arterial hypertension in close relatives. Clin Sci 33: 271-283, 1967
6. Longini IM, Higgins MW, Minton PC, Moll PP, Keller JB: Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh, Michigan. Am J Epidemiol 120: 131-144, 1984
7. Havlik RJ, Garrison RJ, Feinleib M, Kannel WB, Castelli WP, McNamara PM: Blood pressure aggregation in families. Am J Epidemiol 110: 304-312, 1979
8. Wolanski N: An approach to the problem of inheritance of systolic and diastolic blood pressure. Genet Pol 10: 263-268, 1969
9. Hayes CG, Tyroler HA, Cassel CJ: Family aggregation of blood pressure in Evans county, Georgia. Arch Intern Med 128: 965-975, 1971
10. Stocks P: A biometric investigation of twins and their brothers and sisters. Ann Eugenet, 1930
11. McInhai ML, Shaffer JW, Hines EA: The heritability of blood pressure. An investigation of 200 twin pairs using the cold pressure test. J Hopkins Med J 136: 57-74, 1975
12. Havlik RJ, Garrison RJ, Katz SH, Ellison LC, Fienlieb M, Myrianthopulos NC: Detection of genetic variance in blood pressure in seven-years-old twins. Am J Epidemiol 109: 512-516, 1979
13. Feinlieb M, Garrison RJ, Fabsitz R, Chriastian JC, Hrubec Z, Borhani NO, Kannel WB, Rosenman R, Schwartz JT, Wagner JO: The NHLBI twin study of cardiovascular disease risk factors: Methodology and summary of results. Am J Epidemiol 106: 284-295, 1977
14. Oldham PD, Pickering G, Fraser R, Sowry GSC: The nature of essential hypertension. Lancet 1: 1085-1093, 1960
15. Wilsgaard T, Jacobsen BK, Schirmer H, Thune I, Lochen ML, Njolstad I, Arnesen E: Tracking of cardiovascular risk factors: The Tromso study: 1979-1995. Am J Epidemiol 154: 418-426, 2001
16. Burke V, Beilin LJ, Dunbar D: Tracking of blood pressure in Australian children. J Hypertens 7: 1185-1192, 2001
17. O'Sullivan JJ, Derrick G, Foxall RJ: Tracking of 24-hours and casual blood pressure: 1-Year follow-up study in adolescents. J Hypertens 9: 1193-1196, 2000
18. Okasha M, McCarron P, McEwen J, Davey Smith O: Determinants of adolescent blood pressure: Findings from the Glasgow University student cohort. J Hum Hypertens 14: 117-124, 2000
19. Suh I, Nam CM, Kim SI, Lee KH, Kim HC, Kim CS: Twelve-year tracking of blood pressure in korean school children: The Kangwha Study. Yonsei Med J 40: 383-387, 1999
20. McManus IC: Bimodality of blood pressure levels. Statist Med 2: 253-258, 1983
21. Day NE: Estimating the components of a mixture of normal distributions. Biometricka 56: 463-474, 1969
22. Ledley FD, Levy HL, Woo SLC: Molecular analysis of the inheritance of phenylketonuria and mild phenylalaninemia in families with both disorders. N Engl J Med 314: 134-141, 1986
23. Harris H: Enzyme polymorphism in man. Proc Roy Soc B 164: 298-310, 1966
24. Hofman A, Hazebroek A, Valkenburg HAA: A randomised trial of sodium intake and blood pressure in newborn infants. J Am Med Ass 250: 370-373, 1983
25. Geleijnse JN, Hofman A, Witteman JC: A long-term effects of neonatal sodium restriction on blood pressure. Hypertension 29: 913-917, 1997
26. Grollman A, Grollman EF: Teratogenic induction of hypertension. J Clin Invest 41: 710-714, 1962
27. Dahl LK: Salt intake and hypertension. In: Hypertension: Physiopathology and Treatment. Part Two: Physiopathology of Human Experimental Hypertension. Genest J, New York McGraw-Hill, 1983 pp 134-147
28. Krecek J, Dlouha H, Zicha J: Salt supply in early life and possible consequences for hypertension in adult life. Biblthea Nutr Dieta 31: 121-130, 1982
29. Luft FC, Miller JZ, Grim CE: Salt sensitivity and resistance of blood pressure: Age and race as factors in physiological responses. Hypertension 17[suppl I]: 1102-1108, 1991
30. Myers JB, Morgan TO: Effect of alteration in sodium chloride intake on blood pressure in normotensive subjects. J Cardiovasc Pharmacol 6[suppl I]: S204-S209, 1984
31. Zeme I MB, Sowers JR: Salt sensitivity and systemic hypertension in the elderly. Am J Cardiol 61: 7H-12H, 1988
32. Mc Grecor GA, de Wardener HE: Salt, Diet and Health, Cambridge, Cambridge University Press, 1998, pp. 82-99
33. Levy D, De Stefano A, Larson MG, O'Donnell R, Lifton P, Gavras H, Cupples LA, Myers RH: Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension 36: 477-483, 2000
34. rd Edition. Berlin, Springer-Verlag, 1997
35. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G: Polymorphism of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 349: 1353-1357, 1997
36. Dahl LK, Heine M, Tassinari L: Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194: 480-482, 1982
37. Rapp JP: Dahl salt susceptible and salt-resistant rats. Hypertension 4: 753-763, 1982
38. Poch E, Gonzales D, Giner V, Bragulat E, Coca A, de la Sierra A: Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 38: 1204-1209, 2001
39. Hunt S Cook N, Oberman A, Cutler JA, Hennekens CH, Allender AS, Walker GW, Whelton PK, Williams RR: Angiotensinogen genotype, sodium restriction, weight loss and prevention of hypertension. Trials of hypertension prevention, phase II. Hypertension 32: 393-401, 1998
40. Miller JZ, Weiberger MH, Daugherty SA, Fineberg NS, Christian JC, Grim CE: Heterogeneity of blood pressure response to dietary sodium restriction in normotensive adults. J Chron Dis 40: 245-250, 1987
41. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E: C825T polymorphism of the G protein beta(3) subunit and antihypertensive response to a thiazide diuretic. Hypertension 37: 739-743, 2001
42. Glorioso N, Manunta P, Filigheddu F, Troffa C, Stella P, Barlassina C, Lombardi C, Soro A, Dettori F, Pinna Parpaglia P, Sciarrone Alibrandi MT, Cusi D, Bianchi G: The role of alphaadducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 34: 649-654, 1999
43. Cheverud JM, Routman E: Epistasis and its contribution to genetic variance components. Genetics 139: 1455-1461, 1995
44. Frankel W, Schork N: Who's afraid of epistasis? Nature Genet 14: 371-373, 1996
45. Weatherall DJ: Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemia. Nature Rev 2: 245-255, 2001
46. Scriver C, Waters P: Monogenic traits are not simple. TIG 15: 267-272, 1999
47. Wolf U: Identical mutations and phenotypic variation. Hum Genet 100: 305-321, 1997
48. Jeck N, Konrad M, Peters M, Weber S, Bonzel K, Seyberth H: Mutations in the chloride channel gene, CLCNKB, leading to a mixed Barter-Gitelman phenotype. Ped Res 48: 754-758, 2000
49. Lifton RP: Molecular genetics of human blood pressure variation. Science 272: 676-680, 1996
50. Morris B: Genes for essential hypertension: The first decade of research. In: Progress in Hypertension, Part 4, edited by Frossard PM, Utrecht, VSP, 1999, pp 1-44
51. Hamet P, Pausova Z, Adarichev V, Adaricheva K, Tremblay J: Hypertension: Genes and environment. J Hypertens 16: 397-418, 1998
52. Jeunemaitre X, Soubrier F, Kotelevstev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P: Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180, 1992
53. Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, Nembri P, Amar K, Gatti M, Macciardi F, Binelli G, Bianchi G: Association of the alpha-adducin locus with essential hypertension. Hypertension 25: 320-326, 1995
54. O'Donnell CJ, Lindpainter K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D: Evidence for association and genetic linkage of the angiotensin-convertin enzyme locus with hypertension and blood pressure in men but not in women in the Framingham Heart Study. Circulation 97: 1766-1772, 1998
55. Kruskhal J, Xiong M, Ferrell R, Sing CF, Turner ST, Boerwinkle E: Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 7: 1379-1383, 1998
56. Svetkey LP, Chen YT, McKeown SP, Preis L, Wilson AF: Preliminary evidence of linkage of salt sensitivity in black Americans at the b2-adrenergic receptor locus. Hypertension 29: 918-922, 1997
57. Kainulainmen K, Perola M, Terwilliger J, Kaprio J, Koskenvuo M, Syvanen AC, Vartiainen E, Peltonen N, Kontula K: Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33: 844-849, 1999
58. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 104: 545-556, 2001
59. Lander ES, Schork N: Genetic dissection of complex traits. Science 265: 2037-2047, 1994
60. Weeks DE, Lathrop M: Polygenic disease: Methods for mapping complex disease traits. TIG 11: 513-519, 1995
61. Schork NJ: Molecular genetics of hypertension, In Genetics of Hypertension, edited by AD Dominiczack, Connell, Sonbrier, Oxford, Bios S.P. Ltd. 1999, 9-15
62. st centuries: Statistical methods, data analysis and experimental design. Hum Biol 72: 63-132, 2000
63. Guyton A, Hall J, Coleman T: The dominant role of the kidneys in the long-term regulation of arterial pressure in normal and hypertensive states. In: Hypertension, Pathophysiology, Diagnosis and Management, Vol. 1, edited by Laragh JH, Brenner BM, New York, Raven Press, 1990, pp 1029-1052
64. Bianchi G, Fox U, Di Francesco G, Giovannetti AM, Pagetti D: Blood pressure changes produced by kidney-cross transplantation between spontaneously hypertensive and normotensive rats. Clin Sci Mol Med 47: 435-448, 1974
65. Dahl L, Heine M, Thompson K: Genetic influence of the kidney on blood pressure: Evidence from chronic renal homografts in rats with opposite predisposition to hypertension. Circ Res 34: 94-101, 1974
66. Wiss MJ, Oparil S, Chen YF: The role of central nervous system in hypertension. In: Hypertension, Pathophysiology, Diagnosis and Management. Vol. 1, edited by Laragh JH, Brenner BM, New York, Raven Press, 1990, pp 679-701
67. Biglieri EG, Irony I, Kater CE: Adrenocortical forms of hypertension. In: Hypertension, Pathophysiology, Diagnosis and Management. Vol. 1, edited by Laragh JH, Brenner BM, New York, Raven Press, 1990, pp 1609-1624
68. Manger WM, Gifford RW: Pheocromocytoma. In: Hypertension, Pathophysiology, Diagnosis and Management. Vol.2, edited by Laragh JH, Brenner BM, New York, Raven Press. 1990, pp 1639-1660
69. Wilson FH, Dise-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Dessiter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP: Human hypertension caused by mutations in WNK kinase. Science 293: 1107-1112, 2001
70. Klahr S: The role of nitric oxide in hypertension and renal disease progression. Nephrol Dial Transplant 16[Suppl 19]: 60-62, 2001
71. Grant F, Romero JR, Jeunemaitre X, Hunt SC, Hopkins PN, Hollenberg NH, Williams G: Low-renin hypertension, altered sodium homeostasis and alpha-adducin polymorphism. Hypertension 39: 191-196, 2002
72. Hall JE, Guyton A: Control of sodium excretion and arterial pressure by intrarenal mechanisms and the renin-angiotensin system. In: Hypertension, Pathophysiology, Diagnosis and Management. Vol. 1, edited by Laragh JH, Brenner BM, New York, Raven Press, 1990, pp 1105-1129
73. Zhang Y, Mircheff AK, Hensley CB, Magyar CE, Wamock DG, Chambrey R, Yip KP, Marsh DJ, Holstein-Rathlou NH, McDonough A: Rapid redistribution and inhibition of renal sodium transporters during acute pressure natriuresis. Am J Ph Physiol 39: F1004-F1014, 1996
74. Magyar CE, Zhabg Y, Holstein-Rathlou NH, McDonough AA: Downstream shift in sodium pum activity along the nephron during acute hypertension. J Am Soc Nephrol 12: 2231-2240, 2001
75. Barlassina C, Schork N, Manunta P, Citterio L, Sciarrone MT, Lanella G, Bianchi G, Cusi D: Synergistic effect of alpha-adducin and ACE genes in causing blood pressure changes with body sodium and volume expansion. Kidney Int 57: 1083-1090, 2000
76. Manunta P, Burnier M, D'Amico M, Buzzi L, Maillard M, Barlassina C, Lanella G, Cusi D, Bianchi G: Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension 33: 694-697, 1999
77. Ferrandi M, Salardi S, Tripodi G, Barassi P, Rivera R, Manunta P, Goldshleger R, Ferrari P, Bianchi G, Karlisch SJ: Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: Relation to genetic hypertension. Am J Physiol 277: H1338-H1349, 1999
78. Tripodi F, Valtorta F, Torielli L Chieregatti E, Salardi S, Trusolino L, Bianchi G: Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 97: 2815-2822, 1996
79. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, Ardaillou R, Soubrier F: Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 34: 423-429, 1999
80. Staessen J, Wang GJ, Brand E, Barlassina C, Birkenhager W, Herrmann SM, Fagard R, Tizzoni L, Bianchi G: Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertension 19: 1349-1358, 2001
81. Clark CJ, Anderson NH, Farmer R, Friel EC, Fraser R, Connell JM: Alpha-adducin and angiotensin-converting enzyme polymorphisms in essential hypertension. Hypertension 36: 990-994, 2000
82. Lalouel JM, Rohrwasser A: Power and replication in case-control studies. Am J Hypertens 15: 201-205, 2002
83. Mohring J, Mohring B, Naumann HJ, Philippi A, Homsy E, Orth H, Dauda G, Kazda S, Gross F: Salt and water balance and renin activity in renal hypertension of rats. Am J Physiol 228: 1847-1855, 1975
84. Castellano M, Barlassina C, Rossi F, Perani C, Giacche' F, Rivadossi F, Muiesan ML, Beschi M, Tizzoni L, Cusi D, Bianchi G, Agabiti-Rosei E: Age-dependency of alpha-adducin polymorphism modulation of blood pressure [Abstract]. Presented at IX Scientific Meeting of the International Society of Hypertension and XII European Meeting on Hypertension. Prague, June 23-27, 2002
85. Manalich R, Reyes L, Herrera M, Melendi C, Fundora I: Relationship between wight at birth and the number and size of renal glomeruli in humans: A histomorphometric study. Kidney Int 58: 770-773, 200
86. th edition, edited by Massry SG, Glassock RJ, Philadelphia, Lippincott, Williams and Wilkins, 2001, pp 9-13
87. Guron G, Friberg P: An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18: 123-137, 2000
88. Neri Serneri GG, Boddi M, Coppo M, Chechi T, Zarone N, Martelli M, Poggesi L, Margheri M, Simonetti I: Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation 94: 1886-1893, 1996
89. Chadwick IG, O'Toole L, Morice AH, Yeo WW, Jackson PR, Ramsay LE: Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes. J Cardiovasc Pharmacol 29: 485-489, 1997
90. Van Dijk MA, Kroon I, Kamper AM, Boomsma F, Danser AH, Chang PC: The angiotensin-converting enzyme gene polymorphism and responses to angiotensin and bradykinin in the human forearm. J Cardiovasc Pharmacol 35: 484-490, 2000
91. Van der Kleij FGH, de Jong P, Henning R, de Zeeuw D, Navis G: Enhanced response of blood pressure, renal function and aldosterone to angiotensin I in DD genotype are blunted by low sodium intake. J Am Soc Nephrol 2002, in press
92. Duboule D, Wilkins AS: The evolution of "bricolage". Trends Genet 14: 54-59, 1998
93. Glorioso N Filigheddu F, Cusi D, Troffa C, Conti M, Natalizio M, Argiolas G, Barlassina C, Bianchi G: Alpha-adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives. Hypertension 39: 357-362, 2002
94. Sharma AM: The thrifty-genotype hypothesis and its implications for the study of complex genetic disorders in man. J Mol Med 76: 568-571, 1998
95. Neel JV: Diabetes mellitus: A thrifty genotype rendered detrimental by progress? Am J Hum Genet 14: 353-362, 1962
96. Ferrari P, Bianchi G: Genetic mapping and tailored antihypertensive therapy. Cardiovasc Drugs Ther 14: 387-395, 2000
97. Evans W, Relling M: Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 286: 487-491, 1999
98. Roses A: Pharmacoghenetics and the practice of medicine. Nature 405: 857-865, 2000
99. McCarthy J, Hilfiker R: The use of singlenucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol 18: 505-508, 2000